Agentix (AGTX) Other Non Operating Income (2016 - 2026)
Agentix's (AGTX) quarterly Other Non Operating Income came in at $3623.0 in Q1 2026, down 14.71% YoY from $4248.0 in Q1 2025, and up 35.59% on a QoQ basis from $2672.0 in Q4 2025.
Agentix (AGTX) Other Non Operating Income (2016 - 2026) Analysis & Trends
Agentix (AGTX) has 8 years of Other Non Operating Income data on file, last reported at $3623.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 14.71% year-over-year to $3623.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27751.0 (up 197.01% YoY) and the FY2026 annual result came in at $24584.0, up 320.92% from the prior year.
- Other Non Operating Income grew to $3623.0 in Q1 2026, from $2672.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $162868.0 in Q1 2024 to a low of -$35784.0 in Q4 2024.
- A 4-year average of $8563.5 and a median of $2341.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income surged 7848.66% — and 2025, when it sank 97.39%.
- Tracing AGTX's Other Non Operating Income over 4 years: stood at -$25434.0 in 2023, then plunged by 40.69% to -$35784.0 in 2024, then surged by 107.47% to $2672.0 in 2025, then soared by 35.59% to $3623.0 in 2026.
- The last three Other Non Operating Income figures came in at $3623.0 (Q1 2026), $2672.0 (Q4 2025), and $3149.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22,170.00 |
| Mar 31, 2026 | 3,623.00 |
| Dec 31, 2025 | 2,672.00 |
| Sep 30, 2025 | 3,149.00 |
| Jun 30, 2025 | 18,307.00 |
| Mar 31, 2025 | 4,248.00 |
| Dec 31, 2024 | -35,784.00 |
| Sep 30, 2024 | 2,341.00 |
| Jun 30, 2024 | 588.00 |
| Mar 31, 2024 | 162,868.00 |
| Dec 31, 2023 | -25,434.00 |
| Sep 30, 2023 | -18,879.00 |
| Jun 30, 2023 | -8,423.00 |
| Mar 31, 2023 | 2,049.00 |
| May 31, 2019 | 1,481.00 |
| Feb 28, 2019 | 2,932.00 |
| Nov 30, 2018 | 2,328.00 |
| Aug 31, 2018 | -21,834.00 |
| May 31, 2018 | 42.64 Mn |
| Feb 28, 2018 | 7,244.00 |